Assistant Professor J Brett Heimlich

Vanderbilt University Medical Center, Nashville (United States of America)

Membership: ESC Professional Member

Follow

Contributor content

Divergent cardiovascular risk profiles of immune checkpoint inhibitors versus platinum-based chemotherapy in NSCLC: a real-world study of 84,097 patients

Presentation

Divergent cardiovascular risk profiles of immune checkpoint inhibitors versus platinum-based chemotherapy in NSCLC: a real-world study of 84,097 patients

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources